首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis.
【24h】

Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis.

机译:聚合酶链反应酶免疫测定法在外周全血和血清标本中的诊断急性人类布鲁氏菌病的应用。

获取原文
获取原文并翻译 | 示例
       

摘要

A simple polymerase chain reaction-enzyme immunoassay (PCR-EIA) was employed for the rapid laboratory diagnosis of human brucellosis directly from peripheral blood. Whole blood and serum specimens were collected from 243 patients with acute brucellosis as determined by blood culture, serological tests, and the patients' clinical characteristics and from a control group of 50 healthy individuals. Diagnosis of brucellosis was established in 179 cases by isolation of Brucella spp. in blood culture and in 64 cases by clinical signs and serological investigation. Following the amplification of a 223-bp sequence of a gene that codes for the synthesis of an immunogenic membrane protein specific for the Brucella genus, the amplified product was detected in a microtiter plate by hybridization. Two hundred forty-one of the 243 patients tested had detectable Brucella DNA in either whole blood or serum specimens: 149 (61.3%) patients were positive in both whole blood and serum specimens, 43 (17.7%) were positive in serum specimens only, and 49 (20.2%) were positive in whole blood specimens only. The diagnostic specificity of the PCR-EIA assay for both specimen categories was 100%, while the sensitivity was 81.5% for whole blood specimens, 79% for serum specimens, and 99.2% for whole blood and serum specimens combined. The results suggest that the detection of Brucella DNA in whole blood and serum specimens by PCR-EIA assay is a sensitive and specific method that could assist the rapid and accurate diagnosis of acute human brucellosis.
机译:简单的聚合酶链反应-酶免疫分析法(PCR-EIA)用于直接从外周血中快速诊断人布鲁氏菌病。通过血液培养,血清学测试和患者的临床特征,从243名急性布鲁氏菌病患者和50名健康人的对照组中采集全血和血清标本。通过分离布鲁氏菌属确诊了179例布鲁氏菌病。通过临床体征和血清学检查发现血液中有64例患者。扩增编码布鲁氏菌属特异性免疫原性膜蛋白的基因的223 bp序列扩增后,通过杂交在微量滴定板中检测到扩增产物。在测试的243名患者中,有241名在全血或血清标本中均检测到布鲁氏菌DNA:149名(61.3%)患者在全血和血清标本中均为阳性,仅43名(17.7%)在血清标本中为阳性,仅全血样本中有49例(20.2%)呈阳性。 PCR-EIA分析对两种标本的诊断特异性均为100%,而全血标本的敏感性为81.5%,血清标本的敏感性为79%,全血和血清标本的敏感性为99.2%。结果表明,PCR-EIA法检测全血和血清标本中的布鲁氏菌DNA是一种灵敏,特异的方法,可帮助快速,准确地诊断急性人类布鲁氏菌病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号